Empagliflozin Reduces Heart Damage in New Study
Researchers find that the drug helps improve cardiac function by boosting mitochondrial energy production in heart tissues.
Updated on Oct. 24, 2026 in Heart Disease
A study published on October 24, 2026, reveals that empagliflozin reduces myocardial injury in rats by enhancing mitochondrial biogenesis. The treatment significantly improved heart function and reduced signs of cellular stress.
Why it matters
Understanding the mechanisms by which common drugs protect cardiac tissue is vital for developing better therapies for heart failure and related conditions. This research highlights how mitochondrial health serves as a key target for improving long-term cardiovascular outcomes.
The study measured a variety of biomarkers including a decrease in serum levels of BNP, sST2, and cTnT following treatment. Researchers also observed an increase in mitochondrial DNA copy number and ATP production in myocardial tissue.
The players
Empagliflozin
This medication is primarily used to manage blood glucose levels in patients with type 2 diabetes and has been increasingly studied for its cardiovascular benefits.
The details
The drug works by upregulating PGC-1α, a critical mediator of mitochondrial biogenesis, which leads to lower levels of hypertrophy and fibrosis in the heart. When researchers used siRNA to knockdown PGC-1α, the drug lost its ability to provide these protective benefits.
Timeline
October 24, 2026: Article published online
The Big Picture
This study expands upon the foundational results observed in the EMPA-REG OUTCOME trial by uncovering the underlying mitochondrial mechanics that contribute to improved cardiac health.
While this preclinical research identifies how the drug supports mitochondrial function, it does not change current treatment routines for patients. Patients should continue their prescribed heart medication regimens and consult with a doctor regarding any potential changes to their therapy.
The takeaway
This study underscores the crucial role of mitochondrial health in maintaining heart function and preventing fibrosis. Future research will need to confirm whether these cellular mechanisms translate directly to improved treatment pathways for humans.
Further reading
Learn more about advancements in heart health research on the Heart Disease section.
More information
Read the full results in the published scientific research article.
Source note: This article includes information reported by Nature.
